Literature DB >> 9098845

Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease.

J P Kinsella1, T A Parker, H Galan, B C Sheridan, A C Halbower, S H Abman.   

Abstract

To determine the effects of inhaled NO (iNO) on pulmonary edema and lung inflammation in experimental hyaline membrane disease (HMD), we measured the effects of iNO on pulmonary hemodynamics, gas exchange, pulmonary edema, and lung myeloperoxidase (MPO) activity in extremely premature lambs (115 d of gestation, 0.78 term). In protocol 1, we measured the effects of iNO (20 ppm) on lung vascular endothelial permeability to 125I-labeled albumin (indexed to blood volume using 57Cr-tagged red blood cells) during 1 h (n = 10) and 3 h (n = 14) of conventional mechanical ventilation with FiO2 = 1.00. In comparison with controls, iNO improved pulmonary hemodynamics and gas exchange, but did not alter lung weight-to-dry weight ratio or vascular permeability to albumin after 1 or 3 h of mechanical ventilation. To determine whether low dose iNO (5 ppm) would decrease lung neutrophil accumulation in severe HMD, we measured lung MPO activity after 4 h of mechanical ventilation with or without iNO (protocol 2). Low dose iNO improved gas exchange during 4 h of mechanical ventilation (PaO2 at 4 h: 119 +/- 35 mm Hg iNO versus 41 +/- 7 mm Hg control, p < 0.05), and reduced MPO activity by 79% (p < 0.05). We conclude that low dose iNO increases pulmonary blood flow, without worsening pulmonary edema, and decreases lung neutrophil accumulation in severe experimental HMD. We speculate that in addition to its hemodynamic effects, low dose iNO decreases early neutrophil recruitment and may attenuate lung injury in severe HMD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098845     DOI: 10.1203/00006450-199704000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  32 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Monitoring cardiovascular function in infants with chronic lung disease of prematurity.

Authors:  S H Abman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

3.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

Review 4.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 5.  Is nitric oxide effective in preterm infants?

Authors:  Nimish Subhedar; Chris Dewhurst
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09       Impact factor: 5.747

6.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

7.  Association of BPD and IVH with early neutrophil and white counts in VLBW neonates with gestational age <32 weeks.

Authors:  M Palta; M Sadek-Badawi; D P Carlton
Journal:  J Perinatol       Date:  2008-06-19       Impact factor: 2.521

8.  Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Alaadin Polat; Elif Taslidere; Nigar Vardi; Ediz Sarihan; Hilal Ermis; Kevser Tanbag
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

9.  Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats.

Authors:  Richard L Auten; Stanley N Mason; Mary H Whorton; William R Lampe; W Michael Foster; Ronald N Goldberg; Bo Li; Jonathan S Stamler; Kathryn M Auten
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

10.  Persistent fetal circulation.

Authors:  C D'cunha; K Sankaran
Journal:  Paediatr Child Health       Date:  2001-12       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.